Status:
COMPLETED
1,5-AG as a Marker of Postprandial Hyperglycemia and Glucose Variability in Well-controlled Type 2 Diabetes Mellitus
Lead Sponsor:
Kyunghee University Medical Center
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-65 years
Brief Summary
The aim of this study was to evaluate the correlation between 1,5-Anhydroglucitol in patients with HbA1C \<7%, and glycemic excursions as assessed by the continuous glucose monitoring system compared ...
Detailed Description
1,5-Anhydroglucitol (AG) is a glucose analogue present in the plasma of healthy subjects. Physiologically, the plasma levels of 1,5-AG are very stable and only a small quantity is excreted in the urin...
Eligibility Criteria
Inclusion
- HbA1C \< 7%
- HbA1c modification \<0.5% in the previous 3 months
- no recent addition of oral hypoglycemic medications or change in insulin dose \>10% previous 3 months
Exclusion
- pregnancy
- anemia (Hb \<10.0 g/dL)
- liver disease (ALT \>2 UNL)
- hypoalbuminemia (albumin \<3.5 g/dL)
- serum creatinine \>2 mg/dL
- acute or chronic renal tubulointerstitial disease
- severe medical illness
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT01161797
Start Date
February 1 2008
End Date
July 1 2010
Last Update
September 30 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kyunghee University Medical Center
Seoul, South Korea, 130-702